58 life science researchers elected as new EMBO Members
Heidelberg, 23 May 2016 - EMBO today announced that 58 researchers in the life sciences were newly elected to its membership. 50 of the scientists reside in 13 different countries in Europe; eight Associate Members were elected from China, Japan, Lithuania, Singapore and the United States.
New EMBO Members are elected annually in recognition of their contributions to scientific excellence. Their selection is a tribute to their research and achievements.
“I am delighted by the addition of 58 outstanding scientists to our membership. I would like to congratulate them and welcome them to the EMBO community”, EMBO Director Maria Leptin stated. “By serving the principles of excellence and integrity through their views and actions, they make invaluable contributions to science and society.”
The newly elected members and associate members are:
New EMBO Members 2016
Adam Antebi Max Planck Institute for Biology of Ageing, Cologne, Germany M. Madan Babu MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Laure Bally-Cuif Institut de Neuroscience Paris-Saclay, Gif-sur-Yvette, Franc, and Institut Pasteur, Paris, France Mohamed Bentires-Alj Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland Michael Brand Center for Regenerative Therapies, TU Dresden, Germany Dana Branzei IFOM, Istituto FIRC, Milan, Italy Frank Buchholz UCC, TU Dresden, Germany Ana I. Caño-Delgado Centre for Research in Agricultural Genomics, Barcelona, Spain Jason S. Carroll Cancer Research UK Cambridge Institute, Cambridge, United Kingdom Andrew P. Carter MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Agnieszka Chacinska International Institute of Mol. & Cell Biology in Warsaw, Poland Kristina Djinović-Carugo Max F. Perutz Laboratories, University of Vienna, Austria Óscar Fernández-Capetillo Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain, and Karolinska Institute, Stockholm, Sweden Darren Gilmour EMBL, Heidelberg, Germany Ian A. Graham University of York, United Kingdom Manajit Hayer-Hartl Max Planck Institute of Biochemistry, Martinsried, Germany Carl-Philipp Heisenberg Institute of Science and Technology Austria (IST), Klosterneuburg, Austria István Katona Institute of Experimental Medicine of the Hungarian Academy of Sciences, Budapest, Hungary Jan O. Korbel EMBL, Heidelberg, Germany Pekka Lappalainen University of Helsinki, Finland Helder Maiato Instituto de Biologia Molecular e Cellular (IBMC), Porto, Portugal, and Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Portugal Marcos Malumbres Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain Fatima Mechta-Grigoriou Institut Curie, Paris, France Maria M. Mota Instituto de Medicina Molecular, Lisbon, Portugal Daniel J. Müller ETH Zurich, Switzerland Eugene Myers Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany Ove Nilsson Swedish University of Agricultural Sciences, Umeå, Sweden Ruth H. Palmer Gothenburg University, Sweden Jane E. Parker Max Planck Institute for Plant Breeding Research, Köln, Germany Matthieu Piel Institut Pierre Gilles de Gennes, Institut Curie/CNRS, PSL University, Paris, France Simona Polo IFOM, The FIRC Institute of Molecular Oncology, Milano, Italy Hans-Reimer Rodewald Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany Claire Rougeulle CNRS / Université Paris Diderot, Paris, France Raffaella Santoro University of Zurich, Switzerland Uwe Sauer ETH Zurich, Switzerland Hans R. Schöler Max Planck Institute for Molecular Biomedicine, Münster, Germany Melina Schuh Max Planck Institute for Biophysical Chemistry, Göttingen, Germany Roberto Solano Centro Nacional de Biotecnología (CNB), Madrid, Spain Francois Spitz Institut Pasteur, Paris, France Didier Stainier Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany Kate G. Storey University of Dundee, United Kingdom Peter ten Dijke University Medical Centre, Leiden Pavel Tomancak Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany Ian Tomlinson Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom Jernej Ule The Francis Crick Institute and UCL Institute of Neurology, London, United Kingdom Antonella Viola Università di Padova, Italy Douglas J. Winton University of Cambridge, Cambridge, United Kingdom Gulnara Yusupova Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France Xiaodong Zhang Imperial College London, United Kingdom Juleen R. Zierath Karolinska Institutet, Stockholm, Sweden
New Associate EMBO Members 2016
George Fu Gao Chinese Academy of Sciences, Beijing, China, and Chinese Center for Disease Control and Prevention, Beijing, China Hiroshi Hamada RIKEN Center for Developmental Biology, Kobe, Japan Marc W. Kirschner Harvard Medical School, Boston, United States Timothy J. Mitchison Harvard Medical School, Boston, United States Huck-Hui Ng Genome Institute of Singapore, Singapore Virginijus Siksnys Institute of Biotechnology, Vilnius University, Lithuania Hong Wu Peking University, Beijing, China Xiaowei Zhuang HHMI, Harvard University, Cambridge, United States
An online directory with all existing and new EMBO Members can be found at people.embo.org.
About EMBO
EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information: www.embo.org.
Media contact: EMBO Tilmann Kiessling Head, Communications [email protected] Mobile: + 49 160 9019 3839